Botox resistance and COVID-19 vaccines: Is type B Botox a viable solution? uri icon

Overview

publication date

  • September 2, 2023

Research

keywords

  • Botulinum Toxins, Type A
  • COVID-19
  • Neuromuscular Agents

Identity

Scopus Document Identifier

  • 85169534323

Digital Object Identifier (DOI)

  • 10.1111/jocd.15987

PubMed ID

  • 37658662